OPTISCAN IMAGING LIMITED (OIL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

OIL - OPTISCAN IMAGING LIMITED

FNArena Sector : NONE
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: N/A
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.076

28 Mar
2024

0.000

OPEN

$0.08

0.000

HIGH

$0.08

62,231

LOW

$0.08

FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-0.7
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx1.7 M
Book Value Per Share xxxxxxxxxxxxxxx0.5
Net Operating Cash Flow xxxxxxxxxxxxxxx-3.2 M
Net Profit Margin xxxxxxxxxxxxxxx-258.99 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-90.31 %
Return on Invested Capital xxxxxxxxxxxxxxx-85.41 %
Return on Assets xxxxxxxxxxxxxxx-68.77 %
Return on Equity xxxxxxxxxxxxxxx-90.31 %
Return on Total Capital xxxxxxxxxxxxxxx-99.79 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-3.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx0 M
Long Term Debt xxxxxxxxxxxxxxx0 M
Total Debt xxxxxxxxxxxxxxx0 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx1 M
Price To Book Value xxxxxxxxxxxxxxx16.46

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.1 M
Capex % of Sales xxxxxxxxxxxxxxx7.55 %
Cost of Goods Sold xxxxxxxxxxxxxxx1 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx6 M
Research & Development xxxxxxxxxxxxxxx2 M
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

OIL STOCK CHART

FNArena News on OIL